Represented Sightlife II, LLC, a fund managed by Stradling client Flying L Partners, in connection with its investment in the Series B financing of CorneaGen, Inc. Sightlife II co-led the financing.
Flying L Partners is an investment partnership focused on bringing meaningful innovation to the ophthalmic sector and creating value for investors.
CorneaGen is a mission-driven company committed to transforming how corneal surgeons treat and care for the cornea. Based in Seattle, the company is innovating the next generation of cornea care, from new medical devices and biologics to treatments and interventions. CorneaGen supports corneal surgeons and their patients with a spectrum of services, including the latest in innovative products, delivery of the highest quality tissue, surgeon education, and advocacy for patient access and reimbursement policies.
The Newport Beach-based deal team representing Flying L/Sightlife was led by Bruce Feuchter, with Jeff Estes advising the client on CorneaGen financing-related matters, and Ryan Gaglio and Jon Krane (SM) advising the client on fund formation matters.